Dwayne 'The Rock' Johnson TRT: Hypothesized Full Protocol

What Dwayne Johnson Has Actually Said About Steroids and Hormones

Dwayne Johnson is one of the few elite entertainers to have addressed performance-enhancing drug use directly and on the record. The starting point for any honest analysis of his hypothesized protocol is what he has confirmed, what he has denied, and what he has simply declined to discuss.

The 1999 Flex Magazine Admission

In a 1999 interview with Flex Magazine, Johnson confirmed he experimented with steroids at age 18 or 19 alongside a high school friend. He described the experience as brief and said he stopped quickly after buying "a couple of vials." This remains the only on-the-record admission of anabolic steroid use by Johnson, and it predates his professional wrestling career with WWE.

That admission is clinically relevant for one reason: exogenous androgen exposure, even brief exposure during late adolescence, can disrupt hypothalamic-pituitary-gonadal (HPG) axis function. Research published in the Journal of Clinical Endocrinology and Metabolism shows that even short courses of supraphysiologic androgens suppress endogenous luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion, with recovery timelines varying widely by duration of exposure, dose, and individual biology. [1]

Denials of Adult Steroid Use

Johnson has repeatedly denied using anabolic steroids as an adult. In a 2009 conversation documented by multiple entertainment outlets, and in subsequent social media posts, he attributed his adult physique to disciplined training, diet, and genetics. He has not publicly addressed whether he uses physician-prescribed testosterone replacement therapy (TRT) for hypogonadism, which is a distinct and legal medical treatment separate from anabolic steroid use.

Why the Distinction Matters

TRT and anabolic steroid abuse are not the same thing medically or legally. The Endocrine Society's 2018 Clinical Practice Guideline on Testosterone Therapy in Men with Hypogonadism defines TRT as physiologic testosterone replacement targeting serum testosterone levels in the normal male range (generally 300-1,000 ng/dL), prescribed only after documented biochemical deficiency. [2] Anabolic steroid abuse involves supraphysiologic doses with no medical supervision. Johnson denying steroid use does not, by itself, address whether he receives medically supervised TRT.

Why Physicians Suspect Hormone Optimization in Men Johnson's Age and Size

This section is inference, not confirmed fact. The clinical reasoning is based on epidemiology, physiology, and public observation of Johnson's physique over two decades.

Testosterone Decline After 40 Is Well-Documented

The Massachusetts Male Aging Study, which followed 1,709 men over 9 years, found that total testosterone declines at approximately 1.6% per year after age 40, with free testosterone declining even faster at roughly 2-3% per year. [3] At age 52, Johnson would statistically carry testosterone levels meaningfully below his peak if receiving no intervention. Men with Johnson's training volume may see additional suppression: research in the European Journal of Applied Physiology found that high-volume, high-intensity resistance training without adequate recovery can transiently suppress LH and testosterone. [4]

Lean Mass Retention in the Fifth Decade

Maintaining 250-plus pounds of lean body mass past age 50 without hormonal support is physiologically uncommon. A 2020 study in the Journal of Cachexia, Sarcopenia and Muscle confirmed that muscle cross-sectional area declines at roughly 1-2% per year after age 50 in untreated men, even in those who continue resistance training. [5] Johnson's publicly visible physique shows no sign of the characteristic age-related recomposition that appears in elite athletes who retire or reduce training intensity. This is an observation, not a diagnosis.

Recovery Capacity and Sleep

Johnson is well-documented to train at 4 AM, log high weekly training volumes, and maintain a filming schedule that runs 14-plus hours per day. The American Academy of Sleep Medicine position statement notes that sleep deprivation of even modest degree suppresses overnight GH pulse amplitude and reduces testosterone bioavailability. [6] Men managing that kind of schedule with elite-level body composition commonly work with sports medicine physicians and endocrinologists to monitor hormone panels.

The Hypothesized Protocol: Physician-Constructed Inference

The following protocol is a physician-constructed hypothesis built on three inputs: Johnson's confirmed statements, published clinical norms for men over 50 with his training profile, and publicly observable physique data. Nothing below is confirmed by Johnson, his physicians, or his representatives. It is presented as an educational framework for understanding what medically supervised hormone optimization might look like for a man of his age, size, and activity level.

Testosterone Replacement Therapy (Hypothesized)

Agent: Testosterone cypionate or testosterone enanthate (both FDA-approved for hypogonadism) [7]

Hypothesized dose: 100-200 mg injected intramuscularly or subcutaneously once weekly

Clinical rationale: The Endocrine Society guideline recommends testosterone therapy for men with consistently documented serum total testosterone below 300 ng/dL along with signs and symptoms of hypogonadism. [2] A weekly dose of 100-200 mg cypionate typically produces trough levels in the 400-700 ng/dL range in most men, which is within the physiologic window. The American Urological Association (AUA) 2018 guideline on testosterone deficiency uses a similar threshold and emphasizes that treatment goals should target symptom relief and physiologic levels, not supraphysiologic concentrations. [8]

Monitoring standard: Per AUA guidance, men on TRT should have hematocrit checked at 3-6 months (polycythemia risk rises above hematocrit of 54%), PSA monitored annually for men over 40, and serum testosterone measured at trough to confirm therapeutic range. [8]

Growth Hormone (Hypothesized)

Agent: Recombinant human growth hormone (somatropin), FDA-approved for adult GH deficiency [9]

Hypothesized dose: 1-3 IU per day subcutaneously, consistent with adult replacement dosing

Clinical rationale: GH secretion declines roughly 14% per decade after age 30, a process called somatopause. [10] Adult GH deficiency diagnosed by stimulation testing (most commonly the insulin tolerance test or GHRH-arginine test) qualifies for FDA-approved somatropin therapy. At 1-3 IU/day, effects include improved body composition (reduced fat mass, preserved lean mass), improved recovery time, and improved sleep architecture. A meta-analysis of 22 randomized trials published in the Annals of Internal Medicine found that GH replacement in GH-deficient adults reduced fat mass by 2 kg and increased lean mass by 2 kg on average compared to placebo. [10]

At supraphysiologic doses (which this hypothesis does not assume), GH carries risks including insulin resistance, carpal tunnel syndrome, and acromegalic changes. The hypothesized dose here reflects replacement, not abuse.

Ancillary Medications (Hypothesized)

Men receiving exogenous testosterone typically require co-administration of agents to manage downstream hormonal effects. The following are standard in medically supervised TRT and would be expected components of any protocol for a man of Johnson's size.

Anastrozole (aromatase inhibitor): Testosterone converts to estradiol via aromatase, particularly in adipose tissue. Men with higher body mass and muscle mass can produce more estradiol, leading to symptoms including water retention and gynecomastia. Anastrozole at 0.25-0.5 mg twice weekly is a common dose to manage estradiol in men on TRT, though the Endocrine Society cautions against routine use in all TRT patients because estrogen plays a role in bone density, libido, and cardiovascular health. [2]

Human chorionic gonadotropin (hCG): Exogenous testosterone suppresses LH, which reduces intratesticular testosterone production and causes testicular atrophy. HCG mimics LH and can preserve intratesticular testosterone and testicular volume. Doses of 500-1,000 IU two to three times weekly are commonly used. A clinical review in Fertility and Sterility confirmed that hCG co-administration during TRT preserves spermatogenesis better than testosterone alone. [11]

Peptides (speculative): Numerous fitness media sources have speculated that Johnson uses peptide secretagogues such as sermorelin or ipamorelin to stimulate endogenous GH release. These compounds are not FDA-approved for body composition and remain outside any confirmed or hypothesized medically supervised framework. This article does not include them in the primary hypothesized protocol.

What Johnson's Physique Timeline Tells Us Clinically

Johnson's physique from his early WWE career (1996-2004) to his current film work shows a trajectory that sports medicine physicians describe as consistent with optimized rather than suppressed endocrine function across the decades. That observation has a clinical interpretation but not a clinical conclusion.

Early Career: Ages 24-32

During his WWE run, Johnson competed at roughly 260 lbs at 6'5". His physique in this period was large but showed the definition variability typical of high-volume athletic training without strict caloric control. Steroid use in professional wrestling during this era was extensively documented; a 2007 investigative report named in the U.S. House of Representatives Oversight Committee hearing cited widespread anabolic steroid prescribing through online pharmacies to professional wrestlers. Johnson was not named in those proceedings.

Mid-Career: Ages 33-45

During his transition to full-time film work, Johnson maintained his physique through a training model documented in multiple long-form magazine profiles. His body composition during this period, roughly 2007-2018, remained stable despite the metabolic challenges of aging, caloric demands of film schedules, and the natural testosterone decline men experience through their 40s.

Current: Ages 46-52

The current physique, visible in productions like "Black Adam" (2022) and ongoing social media content, shows continued lean mass retention with age. Black Adam required a specific physical preparation that Johnson discussed openly in interviews, referencing the intensity of the pre-production training block. No hormonal disclosures were made in those interviews.

Clinical Context: TRT Prevalence in Men Over 45

Johnson's hypothesized use, if accurate, would place him in a large and growing population. TRT prescriptions in the United States increased more than threefold between 2001 and 2011 according to data published in JAMA Internal Medicine, with the steepest growth in men aged 40-59. [12] Estimates from a 2020 analysis in the Journal of Urology suggest approximately 2.9 million American men were receiving testosterone therapy as of 2016. [13]

The Endocrine Society's guideline authors write directly on this point: "We suggest making the diagnosis of androgen deficiency only in men with consistent symptoms and signs and unequivocally low serum testosterone levels." [2] That framing means TRT in a symptomatic man with confirmed low testosterone is standard-of-care medicine, not a performance-enhancing shortcut.

Risks and Monitoring in Any TRT Protocol

Any medically supervised protocol for a man of Johnson's age must include structured monitoring. The AUA guideline specifies the following minimum monitoring schedule for men on TRT. [8]

Cardiovascular Risk

The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine in 2023, found that testosterone therapy in middle-aged and older men with hypogonadism and existing cardiovascular risk did not increase the rate of major adverse cardiovascular events compared to placebo over a mean follow-up of 33 months. [14] This was a landmark result that helped clarify a years-long debate. The hazard ratio for major adverse cardiovascular events was 0.96 (95% CI 0.83-1.12, P<0.001 for non-inferiority). A secondary finding was a modestly higher rate of atrial fibrillation in the testosterone group (3.5% vs. 2.4%).

Erythrocytosis

Testosterone stimulates erythropoiesis. Hematocrit above 54% raises venous thromboembolism risk. The AUA guideline recommends dose reduction or temporary cessation if hematocrit exceeds that threshold. [8]

Prostate Safety

Per the Endocrine Society, TRT is contraindicated in men with known or suspected prostate cancer, PSA above 4 ng/mL without urologic evaluation, or a prostate nodule on digital rectal exam. [2] Annual PSA monitoring is standard for men on TRT who are over 40.

What We Do Not Know and Cannot Claim

Johnson has not confirmed TRT. He has not confirmed HGH use as an adult. His personal physician has not made any public statements. The hypothesized protocol above is an educational exercise built on clinical guidelines, physique observation, and population epidemiology. It should not be read as an accusation, a diagnosis, or a confirmed fact.

Several clinical possibilities exist. Johnson may have naturally favorable testosterone genetics and remain in a normal range without intervention. His training and dietary discipline may produce hormonal outcomes that differ from population averages. He may receive medically supervised TRT that he has chosen not to disclose. Any of these scenarios is possible based on available public information.

The clinically accurate statement is this: a 52-year-old man with Johnson's training history, body composition, and schedule who presents to an endocrinologist or urologist would receive a full hormone panel and, if his testosterone falls below 300 ng/dL with symptomatic hypogonadism, would be a candidate for TRT under both Endocrine Society and AUA guidelines.

How to Pursue Your Own Hormone Evaluation

Men reading this article who are curious about their own testosterone levels do not need to speculate about celebrity protocols. A fasting morning serum total testosterone test, ideally drawn between 7 AM and 10 AM on two separate days, is the starting point recommended by the Endocrine Society. [2] The CDC's National Health and Nutrition Examination Survey (NHANES) establishes the reference range for total testosterone in healthy men aged 19-39 as approximately 264-916 ng/dL, with age-adjusted declines expected above 40. [15]

If total testosterone is below 300 ng/dL on two separate draws, with symptoms including reduced energy, decreased libido, loss of lean mass, or mood changes, a referral to a urologist or endocrinologist is appropriate. The AUA recommends baseline PSA, hematocrit, and a discussion of fertility goals before initiating any testosterone therapy. [8]

Starting dose for most men new to TRT is testosterone cypionate 50-100 mg weekly, titrated based on trough levels drawn 6-7 days after injection, with a target trough of 400-700 ng/dL for most clinical programs.